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Is EBV Persistence In Vivo
a Model for B Cell Homeostasis?
Gulfaraz Khan,* Emily M. Miyashita,* the assays used for the PCR studies were only sensitive
enough to measure the relative genome copy number.Bin Yang, Gregory J. Babcock,
However, it is known that latently infected cells in vitroand David A. Thorley-Lawson
can contain multiple copies of the viral genome that canDeparment of Pathology
range from 5–500 (Sugden et al., 1979) and that cellsTufts University School of Medicine
replicating the virus contain thousands of genomesBoston, Massachusetts 02111
(Summers and Klein, 1976). Thus, the PCR assays could
only compare relative burdens of viral DNA. They could
not measure the actual numbers of infected cells in anSummary
individual and could not, therefore, be used meaningfully
to compare measurements of the number of infectedWe have measured the absolute numbers of EBV-
cells either within or between individuals. For example,infected B cells in the peripheral blood of healthy per-
it is well established that the viral genome burden in-sistently infected individuals. Single measurements on
creases in immunosuppressed individuals (Saito et al.,a panel of 15 healthy individuals demonstrate that the
1989; Telenti et al., 1990). But the PCR-based assaysfrequency varies over a wide range from 1–50 per 106
could not distinguish what part of this was due to anB cells. Repeat measurements over 1–3.5 years on
absolute increase in the numbers of latently infectedseveral individuals whose frequencies varied over a
cells and what part was due to a switch to viral replica-10-fold range showed that the variation does not rep-
tion, which would also increase the number of viral ge-resent the fluctuation in the frequency that can occur
nomes per cell. To resolve these issues, we set out towithin an individual; rather, the frequencies are spe-
develop a DNA PCR-based assay that would allow uscific to the individual. The frequency within an individ-
to detect a single viral genome in the presence of asual measured over time is stable and contributes less
many as 106 uninfected cells. Using this assay, it wasthan 10% to the variance seen in the whole population.
possible to demonstrate that the virus was present inThese measurements suggest that the level of EBV-
vivo in B cells that had a cell surface phenotype (CD232,infected B cells is tightly regulated and we propose
CD80(B7)2) that had not been observed previously (Miy-that the same homeostatic mechanisms that regulate
ashita et al., 1995). Subsequent studies demonstratedthe levels of normal B cells also regulate Bcells latently
that these cells are latently infected (Decker et al., 1996),infected with EBV.
resting and express the LMP2A gene (E. M. M. et al.,
unpublished data). EBV latency in a resting B cell hadIntroduction
not been described previously and raises the question
as to how the virus establishes itself in this populationEpstein–Barr virus (EBV) is a member of the herpesvirus
of cells and how its numbers are maintained.group (reviewed by Kieff, 1996; Rickinson and Kieff,
During the course of our studies on the phenotype of1996). These viruses are characterized by the ability to
EBV-infected B cells in vivo, we measured the frequency
persist for the life of the infected host. The molecular
in a small panel of donors. When the measurements
and cellular mechanisms underlying this persistence are
were repeated on two individuals 2 years later, they
only now beginning to be understood. Much thinking
showed remarkably little variation over time, raising the
about EBV persistence has been fueled by observations
possibility that the frequency was regulated and individ-
on tumor cells and in vitro infected cell lines. Studies in
ual specific. We have now tested this prediction by mea-
vivo have been hampered by the very low frequencies
suring frequencies in a larger panel of individuals over
of virus-infected B cells and the fact that variable num- the course of 1–3.5 years. This study reports the abso-
bers of genome copies are present in infected cells
lute numbers of EBV-infected cells in a panel of healthy
depending on the form of the infection. Previous studies
individuals and substantiates the prediction that the fre-
have employed either biological assays, termed sponta-
quency is individual specific, stable over long periods
neous outgrowth (Rickinson et al., 1985; Yao et al., 1985, of time, and therefore regulated.
1989, 1991; Lam et al., 1991), or DNA polymerase chain
reaction (PCR) (Saito et al., 1989; Ambinder et al., 1990; Results
Telenti et al., 1990; Wagner et al., 1992). Spontaneous
outgrowth depends on the ability to detect the release The Absolute Frequency of EBV-Infected
of infectious virus through immortalization of bystander Cells in a Healthy Population over Time
cells. However, we do not know how heterogeneous the We have measured the frequency of EBV-infected cells
infected cell population is, how it varies over time and in the B cells of a panel of 15 healthy donors. We have
between individuals, or the efficiency of the outgrowth previously shown that all of the infected cells in healthy
assay at detecting different forms of infection. There- individuals reside in the CD191 B cell fraction of the E
fore, this assay cannot be used to estimate the true rosette–negative population. Therefore, the frequencies
number of infected cells or to compare measurements were measured after depletion of T cells by rosetting to
made within or between individuals. On the other hand, sheep redblood cellsor enrichment of B cells by positive
selection with a CD19 monoclonal antibody. The fre-
quency of infected cells was then measured using a*These authors contributed equally to the work in this paper.
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Table 1. Frequency of EBV-Infected Cells in a Population of Healthy Donors over Time
Frequency/107 B cells over time (years)
Donor 0 0.5 1.0 2.0 2.5 3.0 3.5




5 290 625B — 250 — 220B —
6 100 — — — — 72 86
7 460 — — — 500B 250B 64
8 25
9 40 25 — 90 — 64 —
10 10
11 90B — 96B




Frequencies were estimated on E2 cells and were calculated from the frequency of EBV-infected cells in the population and the percentage
of B cells as estimated by FACS analysis. In some cases, the frequencies were measured on purified B cells and these cases are denoted
with a B. Since the values for the frequencies demonstrated a skewed distribution, we generated a data set with a normal distribution by
taking the natural logarithm of the values. This allowed the estimation of the standard deviation (S), and the variance (S2) for the In data from
the whole population denoted S2T. To calculate the best estimate of the variance in measurements within individuals, the values for S2 for
repeat measurements on each individual were combined to give a pooled estimate, S2W. For details see Experimental Procedures.
limiting dilution DNA PCR analysis correcting for the individual. Therefore, we may conclude that the fre-
quency is individual specific and stable over time.percentage of B cells as assessed by FACS analysis.
Table 1 summarizes the frequencies of EBV-infected B
Is the Assay Sensitive Enough to Detect a Singlecells in the peripheral blood for the panel of 15 healthy
Cell Containing 1–2 Copies of the Viral Genome?donors. The frequencies ranged from 10–460 per 107 B
To substantiate the analysis made above, we performedcells. In Table 1 we also summarized the accumulated
three control experiments to establish the sensitivitydata from multiple estimates on seven of these individu-
and reproducibility of the PCR assay. First, a limitingals over the course of a 1–3.5 year period. By visual
dilution analysis was performed using the Namalwa cellinspection, it appeared that the variation in the fre-
line, which is known to have one or two copies of thequency measurements within individuals was much
viral genome. If the assay detects single events then,smaller than between individuals, suggesting that the
according to the Poisson distribution, a straight linefrequency may be stable and individual specific. To see
should be generated when the number of cells per sam-whether this conclusion could be validated by statistical
ple is plotted against the logarithm of the fraction ofanalysis, we calculated the relative contribution of the
negative samples and this was found to be the casevariance in repeated observations made on the same
(data not shown). The sensitivity and reproducibility ofindividuals to the variance in observations made be-
the assay were also tested by using the fluorescence-tween individuals. The distribution of values between
activated cell sorter to sort single Namalwa cells intoand within individuals was definitely skewed; therefore,
wells of a microtiter plate and showing that the PCRwe calculated the natural log of the values (Winer, 1971),
was 96% reliable (23 of 24 samples were positive; data
which generated a data set that had a normal distribu-
not shown). In control sorts, the cell sorter was 98%
tion. Analysis of the ln data derived from Table 1 yielded
efficient at delivering fluorescence-labeled beads into
a mean value of 4.14 with a standard deviation (ST) of the wells, therefore it is likely that the one negative result
1.10, giving a variance for values on the total population in the PCR can be accounted for by failure to deliver a
(S2T) of 1.210. cell into the well rather than failure of the PCR. Last, the
To calculate the best estimate of the variance in mea- reproducibility of the assay for detecting single copies
surements within individuals, we combined all of the of the viral genome was tested by demonstrating that
data from the individuals for whom we had repeat mea- the PCR could reproducibly (>99%) detect the DNA from
surementsover time (for detailssee Experimental Proce- one viral genome when diluted with the DNA from 106
dures). This gave a pooled estimate of the variance in uninfected cells (data not shown). These control experi-
measurements within individuals (S2W) (Winer, 1971) of ments confirm that the assay will detect a single viral
0.097. The variance between individuals (S2B) can then genome in a single cell and demonstrate that the PCR
be derived by subtracting the variance within individuals is reproducible, i.e., that there is no technical error inher-
(S2W 5 0.097) from the total population variance (S2T 5 ent in the protocol that causes it to fail more than 2% of
1.21), i.e., 1.21 2 0.097 5 1.113. the time when low genome copies are being measured.
Fromthis analysis, we may conclude that >90% (1.113
of 1.21) of the variance seen in the whole population How Accurate Are the Frequency Measurements
can be accounted for by variance between individuals and How Stable Is the Frequency in an Individual?
and <10% (0.097 out of 1.21) is due to the variance An example of the results for purified B cells from one
donor are shown in Figure 1. We have used both E2seen in multiple measurements over time in the same
EBV-Infected B Cell Frequency Is Stable over Time
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Figure 1. An Example of an Analysis of Pe-
ripheral Blood Mononuclear B Cells for the
Presence of EBV
B cells were prepared from the peripheral
blood using the MACS magnetic fractionation
method with the pan-B cell antibody against
CD19, as described in Experimental Proce-
dures. DNA PCR analysis was performed on
limiting dilutions of the purified B cells and
FACS analysis was performed to estimate the
purity of the B cells.
(A) Southern blot of the PCR products. The
cell numbers tested were the following: 5 3
105, 2 3 105, 1 3 105, and 5 3 104 per sample.
Lanes with experimental samples are labelled
with a vertical line, positive controls with a
plus, and negative controls with a minus.
(B) FACS analysis of the purified B cell popu-
lation used for the limiting dilution analysis.
The cells were stained for the pan-B cell
marker CD20.
(C) The results from (A) are plotted using a
semilog scale and demonstrate that the dilu-
tion analysis follows a Poisson distribution.
Therefore, the frequency was estimated by
calculating the number of cells for which the
fraction of negative samples was 0.37. The 6
error was calculated by drawing lines through
the most extreme high and low data points
(designated with dotted lines) and calculating
frequencies from these lines. This analysis
yields a raw frequency of 71 6 14 infected
cells per 107 total cells. FACS analysis re-
vealed that the purified B cell population was
74% B cells; therefore, the corrected fre-
quency was 96 6 19 per 107 B cells.
cells and purified B cells and the frequency was always conclude with certainty that the variation seen in mea-
surements within individuals; for example, the high valuecalculated based on the limiting dilution analysis and
the percentage of B cells in the preparations, as as- of 625 at 0.5 years for donor 5, is significant. Therefore,
within the experimental error of the assay (< 630%),sessed by FACS analysis, since we have shown that
all of the infected cells in peripheral blood are B cells the frequencies are stable over time.
(Miyashita et al., 1995). Figure 2 shows the data obtained
from fourdifferent donors. Taking the most extreme data Discussion
points from each set of measurements, it is possible to
calculate a maximum and minimum value for the fre- In this paper, we report that the absolute frequency of
quency. From these values, it is possible to make a EBV-infected B cells in the peripheral blood of a panel
conservative estimate that the error in the frequency of healthy donors is between 1–50 per 106 B cells. We
measurement is no more than 630%. This was con- have also performed repeat measurements over the
firmed in a separate experiment in which the E2 cells course of 1–3.5 years on several of these donors whose
from the same donor (donor 12) were assayed indepen- individual frequencies varied over a 10-fold range. These
dently three times, using three serial dilutions each time. measurements showed that this variation in frequency
The values obtained were 120 6 40, 90 6 30, and 95 6 does not reflect the variation that occurs within an indi-
50. Taking the extreme values, the largest error in a vidual; rather, a particular individual has a specific and
single estimate was no more than 650%; however, com- stable frequency over time, such that it remains un-
parison of the actual frequencies, measured in the three changed within the sensitivity of the assay for at least
assays, suggests an error closer to 20% (97 6 20). Since 1–3.5 years. This suggests tight regulation of the level
an error of 630%–50% is sufficient to account for the of EBV-infected B cells. How are they regulated? Re-
cently, an emerging picture has been forming of howvariance (S2W) within individuals, it is not possible to
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to be the site of long-term viral persistence. We have
suggested the term “latency program” to describe this
novel form of EBV latency (Thorley-Lawson et al., 1996),
distinguishing it from latent gene expression associated
with immortalization (the growth program), usually re-
ferred to as latency 3 (Rowe et al., 1987).
How do these resting cells maintain a constant fre-
quency? Suggestive evidence for a mechanism comes
from studies on the EBNA-1 protein. EBNA-1 is essential
for the replication of the latent episomal viral genome
(Yates et al., 1985) and contains a domain that prevents
it from being processed and presented as a CTL target
(Levitskaya et al., 1995). Therefore, EBNA-1 can be ex-
pressed in a proliferating B cell without being detected
by the immune response. Thus, it is likely that the latently
infected resting B cells sporadically go through periods
of proliferation in which only EBNA-1 is expressed, a
condition that we refer to as “EBNA-1 only” latency.
Seen in this light, EBV persistence is a balance be-
tween a pool of LMP2A1 resting B cells and periodic
transition through a proliferating EBNA-1 only state,
driven by physiologic signals, to replenish the pool of
latently infected resting B cells. This is analogous to the
maintenance of B cell memory and raises the possibility
that long-term persistence by EBV in the B cell compart-
ment exploits and is a model for long-lived B cell mem-
ory. In the case of EBV infection, the absolute numbers
of EBV-infected cells that enter the B cell pool areproba-
bly a function of a number of factors, including age and
severity of infection, efficiency of the immune response
in clearing the virus and virus-infected cells, and the
genetic background of the individual. The immunologi-
cal equivalent would be the establishment of memory
B cells to a specific antigen. The absolute frequency of
these cells would depend on the severity and frequency
Figure 2. Analysis of the Frequency of EBV-Infected B Cells in the of exposure to the antigen, the efficacy of the immune
Peripheral Blood of Four Donors response, and the genetic background of the individual.
Limiting dilution analysis of the kind exemplified in Figure 1 was Thus, the fraction of B cells that are EBV infected or
performed and the fraction of negative samples was plotted against
recognize a specific antigen both vary considerably be-the number of B cells per sample at each dilution. The number of
tween individuals while being maintained as part of aB cells per sample was estimated from the total number of cells
fairly constant population of total B cells.tested, and the percentage of B cells based on FACS analysis after
staining for the pan-B cell marker CD20. Since we have established Adoptive transfer experiments have led to the conclu-
the validity of the Poisson distribution (Figure 1; data not shown), sion that memory B cells in mice only survive for 10–12
the frequency was estimated by calculating the number of B cells weeks in the absence of antigen. Periodic exposure to
for which the fraction of negative samples was 0.37. The 6 error
antigen is required for them to be long lived (Gray andwas calculated by drawing lines through the most extreme high
Skarvall, 1988), giving rise to memory responses thatand low data points (designated with dotted lines) and calculating
last for decades in the human. Similarly, the populationfrequencies from these lines.
of resting B cells persistently infected with EBV appears
to be maintained stably over long periods of time. This
EBV persists in vivo. The infected cells in the peripheral raises the question of whether fortuitous stimulation by
blood are latently infected and resting (Miyashita et al., cognate antigen plays a role in EBV persistence or
1995; Decker et al., 1996) and do not express thegrowth- whether the signals supplied by antigen are replaced
promoting latent genes (Qu and Rowe, 1992; Tierney et by the actions of the growth-promoting latent genes.
al., 1994; Chen et al., 1995). They do express LMP2A, In this paper, we have also presented a detailed analy-
explaining the absence of viral replication (Decker et al., sis of theDNA PCR assay. This was done both todemon-
1996), since LMP2A is believed to block fortuitous viral strate that it can detect a single genome in a single EBV-
reactivation (Miller et al., 1995). Although LMP2A is a infected cell and to substantiate our claim to measuring
known target for CTL (Masucci and Ernberg, 1994), the absolute numbers of infected cells invivo. The reproduc-
cells may not be lysed because they lack B7 (Miyashita ibility, sensitivity, and accuracy of this assay allows us
et al., 1995), which is required to activate memory CTL to measure the frequency of EBV-infected cells and
responses (Azuma et al., 1992). Therefore, the resting show that it is stable over time to an accuracy within
B7-negative circulating B cell,whose frequency we have the margin of error of the assay < 630%. By contrast,
the variation seen within the population is clearly muchmeasured in these studies, is the proposed candidate
EBV-Infected B Cell Frequency Is Stable over Time
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greater and cannot be accounted for by the variance that contribute to the overall increase in viral burden.
Specifically, we will be able todistinguish a true increasein measurements within individuals, which contributed
less than 10% of the total variance. This leads us to the in the number of infected cells from contributions made
by viral reactivation. In the long run, this should provideconclusion that the frequencies are individual specific.
If the error of the assay is z30%, this is not due to insights into the effects of immunosuppression on EBV
persistence and hopefully define parameters that mayfalse negatives. We do not obtain a significant level of
negative results (<2%) in control experiments in which have predictive value in understanding which particular
individuals are at risk for EBV-associated neoplasia.we have tested multiple samples that are known to be
positive. We have also controlled for this in another way
during actual measurements of frequencies by showing Experimental Procedures
that samples that were negative for EBV were still posi-
Cell Linestive for an internal control sequence, the bcl-2 gene
The Namalwa cell line (American Type Culture Collection) is an EBV-(data not shown).
positive Burkitt’s lymphoma. It contains either one or two integratedIt is unclear at this time whether the most extreme
copies of EBV. It was used for all experiments that tested the sensi-
values for the frequency within an individual represent tivity of the PCR protocol. It was also included in all experiments
genuine fluctuations. The most obvious example of this as a positive control. BJAB (gift of Dr. E. Kieff) is an EBV-negative
is the value of 625 for donor 5 at 0.5 years. The intrinsic B cell lymphoma. It was used to provide filler cells when performing
limiting dilution analysis. A minimum of five samples of 106 BJABerror for the assay that we have measured would not
cells alone were also included in every experiment to act as a nega-be sufficient to account for this unusually high value,
tive control for PCR. The cells were maintained in 10% fetal bovineraising the possibility that there may have been a tran-
serum (Biowhittiker), RPMI 1640 (Mediatech) at 378C in an atmo-
sient increase in the number of infected cells in this sphere of 5% CO2.
individual. However, the error may be larger in measure-
ments taken over longperiods of time. Notwithstanding,
Cell Fractionation
it is striking that even for this individual the frequency The donors in this study were all EBV-positive, ranging in age from
returns to a value remarkably close to the original in 25–60 years. They included three women and twelve men: two His-
panics, four Asians, and nine Caucasians.subsequent measurement 2 and 3 years later.
Peripheral blood (usually 120 ml) was drawn from healthy donorsPrevious estimates of the frequency of EBV-infected
using heparinized syringes. The blood was layered onto Ficoll–cells in the peripheral blood of healthy donors have
Hypaque (Pharmacia). Buffy coats were removed and washed withdepended on the biological assay of spontaneous out-
Heparin (1 U/ml) in 1% fetal calf serum, RPMI 1640. E2 cells were
growth that relies on the infected cells releasing infec- prepared by depleting peripheral blood mononuclear cells (PBMCs)
tious virus that is then detected as immortalization of of T cells (E1) using neuraminidase-treated (GIBCO BRL) sheep red
blood cells (gift from Dr. A. Rabson) as described previously (Hurleybystander B cells. We do not know what fraction of the
and Thorley-Lawson, 1988). Typically, E2 cells contained 20%–40%cells undergo this process, the efficiency of the assay,
B cells. B cells were prepared by positive selection from wholeor the extent to which these parameters vary from time
PBMCs using a monoclonal antibody to the B cell–specific markerto time or from individual to individual. Nevertheless,
CD19 (Dako) and the MACS bead system. First, buffy coats were
many inferences about the nature of EBV persistence removed and washed with RPMI 1640 with 1% fetal calf serum and
have been drawn using this assay, therefore it would be heparin (1 U/ml). PBMCs were resuspended in phosphate-buffered
saline supplemented with 5 mM EDTA, 0.5% BSA (PBSA) at 2 3 107of interest to know how closely the values measured by
cells/ml and aliquoted into 1.5 ml microcentrifuge tubes at 1 ml/outgrowth correlate with the more precise and repro-
tube. Biotinylated antibody was added to each tube and tubes wereducible PCR method. The most extensive use of this
put on a rotator at 48C for 30 min. The cells were then washedassay has been by Yao et al. (1985, 1989, 1991). These
two times with PBSA and MACS streptavidin microbeads (Miltenyi),
authors have reportedthat thenumber of cells giving rise diluted with phosphate-buffered saline to 200 ml, added to each
tospontaneous outgrowth is stable for severalmonths in tube, and incubated for 15 min on ice. The cells were then washed
once and resuspended in PBSA. MACS type AS separation columnsa given individual with values consistent with frequen-
(Miltenyi) were used according to the instructions of the manufac-cies ranging from around 20 to <0.1 per 106 B cells (Yao
turer. In brief, the column was washed with 10 column volumes ofet al., 1985). This suggest that the outgrowth assays
PBSA. The magnetically stained cell suspension was then appliedunderestimate the frequency of infected cells, particu-
to the top of the column and allowed to pass through. The column
larly at the low end. Furthermore, comparison is hin- was then washed with 5 column volumes of PBSA. The collected
dered because the dilutions reported do not always fol- passthrough was the negative fraction. The column was removed
low a Poisson distribution (Yao et al., 1991), making from the magnetic separator, back-flushed with a side syringe, re-
placed back on the magnetic separator, and again washed with 5estimates of frequency problematic. This probably oc-
column volumes of PBSA. The column was then removed from thecurs because the cord blood filler cells used are more
magnetic separator and washed with 5 column volumes of PBSA.efficiently immortalized than the adult donor cells, lead-
The cells that eluted were the positive fraction. The flow rate of the
ing to more efficient outgrowth at lower donor cell column was controlled by using a 23G needle. These preparations
numbers. were always >75% B cells and usually >90% B cells.
Outgrowth assays and DNA PCR have also been used The percentage of B cells in the population to be analyzed was
assessed by staining with an antibody to the B cell–specific markerto demonstrate an increase in the viral burden in the
CD20 (Dako) directly coupled to fluorescein isothiocyanate. As aperipheral blood of immunosuppressed individuals that
negative control, MOPC 21 (IgG1 isotype control, Sigma, St. Louis,has generally been interpreted as an increase in latently
Missouri) was used and propidium iodide was used to distinguish
infected cells (Yao et al., 1985; Saito et al., 1989; Telenti live from dead cells. Samples wereanalyzed using a Becton-Dicken-
et al., 1990). Analysis of a large group of immunosup- son FACScan with Lysys II software.
pressed patients with our assay will allow definitive For analysis of single Namalwa cells, single cells were sorted
with a FACStar Plus cell sorter directly into the wells of a 96-wellstatements to be made about the exact mechanisms
Immunity
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V-bottomed plate that already contained 106 BJAB cells in 0.2 ml for the whole population was definitely skewed (see Table 1), we
calculated the natural log of the values (Winer, 1971), which gener-of medium.
ated a data set that had a normal distribution giving a variance (S2T)
for the total population of 1.124.DNA PCR Analysis for EBV DNA
Since we had repeat measurements on several individuals, weEither non-T (E2) PBMCs or purified B cells were used for analysis
wished to calculate the best estimate of the variance in measure-by PCR. DNA was isolated using a modification of the protocol
ments within individuals (S2W) by pooling all of this data. To do this,of Coen (1990). Cells were pelleted and resuspended with 100 mL
the variance (S2) from the ln values of repeat measurements onproteinase K digestion buffer (1 mg/ml proteinase K, 20 mM EDTA
each individual over time from Table 1 were calculated. These were[pH 8.0], 20 mM Tris [pH 7.4], 0.5% SDS). Cell lysates (100 mL) were
then combined to give a pooled estimate according to the formula:incubatedat 558C for 4–18hr. The lysates were extractedwith 100mL
each of phenol and chloroform-isoamyl alcohol (24:1). The organic
(n1 2 1) S12 1 (n2 2 1) S22phase was back-extracted with 50 ml digestion buffer (without pro- S2W 5 n1 1 n2teinase K) and then extracted twice with an equal volume of chloro-
form-isoamyl alcohol (24:1). The aqueous phase was mixed with 50
where n equals number of measurement on a given individual, S
mL of 10 M ammonium acetate and 2.5 vol of 100% ethanol and
equals the standard deviation of those measurements,and S2 equals
stored overnight at 2208C. The precipitated DNA was pelleted in a
the variance (Winer, 1971).
microcentrifuge for 15 min at 48C and 70% ethanol was used to
∴ From the data in Table I
wash away excess salt. The pellets were air dried and resuspended
in 50 or 25 ml high pressure liquid chromatography H20 (Aldrich) and (0.0495)2 1 3(0.471)2 1
either stored at 2208C or used directly in PCR. 2(0.165)2 1 3(0.333)2 1 3(0.558)2 1 (0.042)2 1 (0.212)2
S2W 5Primers (22 bp) were made from the W repeat region of EBV. They 2 1 4 1 3 1 4 1 4 1 2 1 2
were 59-CTTTAGAGGCGAATGGGCGCCA-39 and 59-TCCAGGGCCT
5 0.097
TCACTTCGGTCT-39 and amplified the region between 14068 and
14562 to give a product of 494 bp. To determine whether the ex- The relative contribution of variance within individuals (S2W) and
tracted DNA was a suitable template for PCR, i.e., test for false between individuals (S2B) to the total variance in the population (S2T)
negatives, we used primers against the single copy cellular gene, is calculated (Winer, 1971) according to the formula:
bcl-2. These were 59-CTTTAGAGAGTTGCTTTACGTG-39 and 59-TC
S2T 5 S2W 1 S2BCATATTCATCACTTTGACAA-39 and generated a PCR product that
Since S2W 5 0.097 (see above)was 277 bp long (Wyatt et al., 1992).
PCRs were performed in a final volume of either 50 or 100 mL and S2T 5 1.210 (from Table 1)
with up to 4 mg of DNA per reaction. The DNA was denatured for S2B 5 1.113∴
10 min at 958C “hot start,” while amplification mixture, containing
20 pmol of each primer, 200 mM dNTPs (Pharmacia), 50 mM KCL, Acknowledgments
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